<DOC>
	<DOCNO>NCT01654211</DOCNO>
	<brief_summary>This three-part study evaluate pharmacokinetics bioavailability intravenous danoprevir without low-dose oral ritonavir , effect oral cyclosporine pharmacokinetics intravenous danoprevir ritonavir healthy volunteer .</brief_summary>
	<brief_title>A Pharmacokinetic And Bioavailability Study Intravenous Danoprevir Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lactams</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Adult healthy male female nonsmoking volunteer , 18 55 year age inclusive ; healthy status define absence evidence active chronic disease follow detailed medical surgical history complete physical examination Pregnant lactate woman male female partner pregnant lactate Positive result drug abuse screen prior admission clinical site study period Positive hepatitis B , hepatitis C HIV infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>